Tscan Therapeutics Inc (TCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 2,027 | 795 | 290 | 0 | 0 |
| Gross Profit | 2,027 | 795 | 290 | N/A | N/A |
| Operating Expenses | 9,945 | 8,605 | 7,461 | 5,616 | 5,636 |
| Operating Income | -7,918 | -7,810 | -7,171 | -5,616 | -5,636 |
| Other Income | 6 | 3 | 1 | 3 | 99 |
| Pre-tax Income | -7,912 | -7,807 | -7,170 | -5,613 | -5,537 |
| Net Income Continuous | -7,912 | -7,807 | -7,170 | -5,613 | -5,537 |
| Net Income | $-7,912 | $-7,807 | $-7,170 | $-5,613 | $-5,537 |
| EPS Basic Total Ops | -6.49 | -8.05 | -7.16 | -6.18 | -7.13 |
| EPS Basic Continuous Ops | -6.49 | -8.07 | -7.16 | -6.17 | -7.13 |
| EPS Diluted Total Ops | -6.49 | -8.05 | -7.16 | -6.18 | -7.13 |
| EPS Diluted Continuous Ops | -6.49 | -8.07 | -7.16 | -6.17 | -7.13 |
| EBITDA(a) | $-7,449 | $-7,414 | $-6,825 | $-5,350 | $-5,414 |